Literature DB >> 19651868

Characterization of a unique ADP-ribosyltransferase of Mycoplasma penetrans.

Coreen Johnson1, T R Kannan, Joel B Baseman.   

Abstract

Mycoplasma penetrans is a urogenital tract pathogen implicated in the deterioration of the immune system in human immunodeficiency virus-infected AIDS patients. Here, we describe a 78-kDa protein from M. penetrans, designated MYPE9110, that exhibits sequence similarity to known ADP-ribosyltransferases (ADPRTs) such as Bordetella pertussis pertussis toxin and Mycoplasma pneumoniae community-acquired respiratory distress syndrome toxin. MYPE9110 possesses key amino acid residues found in all ADPRTs that are essential for ADPRT activity. Several mammalian cell proteins are ADP-ribosylated by MYPE9110, and the full-length recombinant protein exhibits a strong auto-ADP-ribosylating activity. In the absence of target proteins, MYPE9110 demonstrates a NAD-glycohydrolase activity by hydrolyzing NAD. Furthermore, this toxin elicits cytopathology in HeLa cells by inducing cytoplasmic vacuolization in the presence of ammonium chloride. The deletion of the C-terminal region of MYPE9110 significantly diminishes its binding to host cells while still exhibiting an ADPRT activity, suggesting that MYPE9110 is a member of the family of A-B ADPRT toxins.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19651868      PMCID: PMC2747967          DOI: 10.1128/IAI.00044-09

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  36 in total

1.  Pertussis toxin S1 mutant with reduced enzyme activity and a conserved protective epitope.

Authors:  W N Burnette; W Cieplak; V L Mar; K T Kaljot; H Sato; J M Keith
Journal:  Science       Date:  1988-10-07       Impact factor: 47.728

2.  Site-directed mutagenesis by overlap extension using the polymerase chain reaction.

Authors:  S N Ho; H D Hunt; R M Horton; J K Pullen; L R Pease
Journal:  Gene       Date:  1989-04-15       Impact factor: 3.688

3.  ADP-ribosylation of skeletal muscle and non-muscle actin by Clostridium perfringens iota toxin.

Authors:  B Schering; M Bärmann; G S Chhatwal; U Geipel; K Aktories
Journal:  Eur J Biochem       Date:  1988-01-15

4.  Newly discovered mycoplasma isolated from patients infected with HIV.

Authors:  S C Lo; M M Hayes; R Y Wang; P F Pierce; H Kotani; J W Shih
Journal:  Lancet       Date:  1991-12-07       Impact factor: 79.321

5.  In vitro influence of Mycoplasma penetrans on activation of peripheral T lymphocytes from healthy donors or human immunodeficiency virus-infected individuals.

Authors:  Y Sasaki; A Blanchard; H L Watson; S Garcia; A Dulioust; L Montagnier; M L Gougeon
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

6.  NAD-binding site of the C3-like ADP-ribosyltransferase from Clostridium limosum.

Authors:  M Jung; I Just; J van Damme; J Vandekerckhove; K Aktories
Journal:  J Biol Chem       Date:  1993-11-05       Impact factor: 5.157

7.  Potentiation of Helicobacter pylori vacuolating toxin activity by nicotine and other weak bases.

Authors:  T L Cover; S G Vaughn; P Cao; M J Blaser
Journal:  J Infect Dis       Date:  1992-11       Impact factor: 5.226

8.  Adherence, fibronectin binding, and induction of cytoskeleton reorganization in cultured human cells by Mycoplasma penetrans.

Authors:  J A Girón; M Lange; J B Baseman
Journal:  Infect Immun       Date:  1996-01       Impact factor: 3.441

9.  High frequency of antibodies to Mycoplasma penetrans in HIV-infected patients.

Authors:  R Y Wang; J W Shih; T Grandinetti; P F Pierce; M M Hayes; D J Wear; H J Alter; S C Lo
Journal:  Lancet       Date:  1992-11-28       Impact factor: 79.321

10.  Triton X-114 phase fractionation of an integral membrane surface protein mediating monoclonal antibody killing of Mycoplasma hyorhinis.

Authors:  H C Riethman; M J Boyer; K S Wise
Journal:  Infect Immun       Date:  1987-05       Impact factor: 3.441

View more
  5 in total

1.  Identification of lipoprotein MslA as a neoteric virulence factor of Mycoplasma gallisepticum.

Authors:  S M Szczepanek; S Frasca; V L Schumacher; X Liao; M Padula; S P Djordjevic; S J Geary
Journal:  Infect Immun       Date:  2010-06-01       Impact factor: 3.441

2.  Cholera- and anthrax-like toxins are among several new ADP-ribosyltransferases.

Authors:  Robert J Fieldhouse; Zachari Turgeon; Dawn White; A Rod Merrill
Journal:  PLoS Comput Biol       Date:  2010-12-09       Impact factor: 4.475

3.  Mycoplasma iowae: relationships among oxygen, virulence, and protection from oxidative stress.

Authors:  Rachel E Pritchard; Mitchell F Balish
Journal:  Vet Res       Date:  2015-03-21       Impact factor: 3.683

Review 4.  Infection strategies of mycoplasmas: Unraveling the panoply of virulence factors.

Authors:  Chen Yiwen; Wu Yueyue; Qin Lianmei; Zhu Cuiming; You Xiaoxing
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

5.  Mycoplasma pneumoniae CARDS toxin exploits host cell endosomal acidic pH and vacuolar ATPase proton pump to execute its biological activities.

Authors:  Kumaraguruparan Ramasamy; Sowmya Balasubramanian; Alejandra Kirkpatrick; Daniel Szabo; Lavanya Pandranki; Joel B Baseman; T R Kannan
Journal:  Sci Rep       Date:  2021-06-02       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.